Terming the development as Phase 2A, a social media video posted depicted visuals of trials and stations. The final phase of the line is expected to open in Colaba by 2025 end. Once the line opens ...

Rigel Therapeutics expands oncology portfolio with REZLIDHIA & GAVRETO, sees promising R289 results. Click here to read my ...

As companies launched small Phase 1 trials intended to establish the correct ... a senior graphics editor who creates maps, charts and diagrams that provide greater depth and context to stories ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Researchers at National Taiwan University have unveiled an innovative diagnostic tool that significantly improves the speed ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Multi-center international trials are gaining popularity for diverse patient populations. Phase IV (Post-Marketing Surveillance): Conducted after regulatory approval to monitor long-term safety and ...